Latest News in the pharma Industry

Market News

Vectura signs global development agreement with Dynavax

Vectura signs global development agreement with Dynavax

16 Aug 2017

Agreement convers the clinical application of Vectura's proprietary smart nebuliser technology to deliver Dynavax's investigational immunotherapeutic agent to lung cancer patients.

Read more 
Metacrine collaborates on development of FGF1 variants for glucose lowering and improving insulin sensitivity

Metacrine collaborates on development of FGF1 variants for glucose lowering and improving insulin sensitivity

16 Aug 2017

Novo Nordisk will have an option to license the FGF1 program upon achievement of certain research milestones.

Read more 
Abcam and TTP Labtech collaborate to develop sol-R reagent kits

Abcam and TTP Labtech collaborate to develop sol-R reagent kits

16 Aug 2017

Assay-ready kits will incorporate fully-validated, industry-leading recombinant antibody technology for high throughput research.

Read more 
The Great Hall of China: double digit growth at CPhI China

The Great Hall of China: double digit growth at CPhI China

15 Aug 2017

The Asian pharma event surpasses 55,000 visits with more than 10,000 overseas visits.

Read more 
Bespoke filtration equipment enables pharma manufacturer to fulfil contract

Bespoke filtration equipment enables pharma manufacturer to fulfil contract

15 Aug 2017

Major pharma manufacturer delivers critical drugs to a leading children's hospital.

Read more 
Cambridge Epigenetix and NuGEN Technologies combine leading technologies in epigenetics research

Cambridge Epigenetix and NuGEN Technologies combine leading technologies in epigenetics research

15 Aug 2017

Co-exclusive global licence covers manufacture and integration of CEGX TrueMethyl technology for oxidative bisulfite sequencing with Targeted Methylation and NuGEN Ovation Methyl-Seq systems.

Read more 
Fortress Biotech forms new subsidiary, Aevitas Therapeutics

Fortress Biotech forms new subsidiary, Aevitas Therapeutics

14 Aug 2017

Subsidiary to develop novel AAV gene therapy treatments for complement-mediated.

Read more 
Tyme Technologies announces the issuance of two new platform patents

Tyme Technologies announces the issuance of two new platform patents

14 Aug 2017

The two patents represent the next generation of SM-88, joining tyrosine and melanin into a potentially more potent combination.

Read more 
FDA approves liposome-encapsulated combination of daunorubicin-cytarabine for adults with AML

FDA approves liposome-encapsulated combination of daunorubicin-cytarabine for adults with AML

13 Aug 2017

Vyxeos represents the first new chemotherapy advance in more than 40 years for these adults with AML.

Read more 
Mylan launches Avonza in India

Mylan launches Avonza in India

10 Aug 2017

Company is first to offer innovative, reduced-dose HIV treatment in India.

Read more 
CPhI India Report identifies two-tier manufacturing market and predicts increased acquisitions

CPhI India Report identifies two-tier manufacturing market and predicts increased acquisitions

10 Aug 2017

CDSCO certification has improved international repute of India, but domestic companies call for urgent Government support to invest in API facilities.

Read more 
SK Capital agrees to acquire Perrigo API business

SK Capital agrees to acquire Perrigo API business

10 Aug 2017

Transaction is expected to close during Q4 2017, before which a new trade name will be selected for the Business.

Read more